Avenciguat
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Avenciguat, covering 2024-09-04 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms [Phase 2]